RxDoctor Payments Data

Cynthia Planeaux, NP

Nurse Practitioner · Taylor Mill, KYNPI 1972569283

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 389 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 40 manufacturers, the largest accounting for just 21.0% — the pattern of someone who eats at a lot of different presentations. Among nurse practitioner clinicians in KY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$11,040in general payments, 2019–2025

Across 389 payments — averaging $28.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • AstraZeneca$2K
  • Novo Nordisk$1K
  • Bayer$744
  • Lilly USA, LLC$585
  • GSK$453
  • plus $4K from 34 others

What the payments were for

  • Food & beverage$11,040100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,040 in reported general payments places this provider in the 95th percentile of 1,918 nurse practitioner providers in Kentucky.

See all nurse practitioner providers in Kentucky

Medicare billing

Part B allowed, 2024
$50,518
Medicare patients
203
Services billed
1,130

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide62$103,435
FarxigaDapagliflozin Propanediol66$78,978
EliquisApixaban56$74,654
JardianceEmpagliflozin66$72,363
MounjaroTirzepatide30$53,021
Trelegy ElliptaFluticasone/Umeclidin/Vilanter51$51,264
Breztri AerosphereBudesonide/Glycopyr/Formoterol40$43,952
LinzessLinaclotide25$28,804
MyrbetriqMirabegron36$25,829
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr20$11,537
Lantus SolostarInsulin Glargine,hum.Rec.Anlog47$8,830
Humalog Kwikpen U-100Insulin Lispro11$6,803
Novolog FlexpenInsulin Aspart16$6,244
Albuterol Sulfate HfaAlbuterol Sulfate196$6,045
Atorvastatin Calcium488$3,276

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Breztri Aerosphere$1,962$122,930106 claims
Novo NordiskOzempic$1,061$103,43562 claims
PfizerEliquis$259$74,65456 claims
Boehringer IngelheimJardiance$327$72,36366 claims
GSKTrelegy Ellipta, Anoro Ellipta$453$62,80171 claims
Lilly USA, LLCMounjaro$585$53,02130 claims
AbbVieLinzess, Synthroid$2,315$30,16953 claims
Astellas Pharma US IncMyrbetriq$89$25,82936 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,918 nurse practitioner providers in Kentucky.

Other nurse practitioner in Taylor Mill

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →